SRF Limited

Informe acción BSE:503806

Capitalización de mercado: ₹774.7b

SRF Crecimiento futuro

Future controles de criterios 3/6

Se prevé un crecimiento anual de los beneficios y los ingresos de SRF de 16.5% y 12.2% por año respectivamente. Se prevé que el BPA crezca en un 16.9% al año. Se espera que la rentabilidad financiera sea de 15.8% en 3 años.

Información clave

16.5%

Tasa de crecimiento de los beneficios

16.93%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Chemicals19.2%
Tasa de crecimiento de los ingresos12.2%
Rentabilidad financiera futura15.80%
Cobertura de analistas

Good

Última actualización17 May 2026

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Actualización de narrativa Apr 30

503806: Future P/E Compression Will Likely Cap Upside Despite Margin Support

The analyst price target for SRF has been adjusted from ₹2,249.74 to ₹2,200.00 as analysts factor in updated assumptions on discount rate, revenue growth, profit margin and future P/E. What's in the News SRF has scheduled a board meeting on May 05, 2026 to consider and approve the audited financial results for the quarter and year ended March 31, 2026 (company filing).
Actualización de narrativa Apr 08

503806: Fair View As Higher Margins Offset Lower Future P/E Multiple

Analysts have raised their fair value estimate for SRF slightly, from ₹2,239.45 to ₹2,249.74. This reflects updated assumptions for revenue growth, profit margins, a lower assumed discount rate, and a reduced future P/E multiple.
Actualización de narrativa Mar 24

503806: Elevated P E And Margins Will Likely Restrain Future Returns

Analysts have modestly increased their fair value estimate for SRF from ₹2,218.36 to ₹2,239.45, citing updated assumptions regarding revenue growth, profit margins, the discount rate, and future P/E, which together support a slightly higher price target. What's in the News SRF's board approved the appointment of Mr. Samir Kashyap as Chief Financial Officer, effective January 27, 2026.
Actualización de narrativa Mar 09

503806: Elevated P E And Modest Margins Will Likely Restrain Future Returns

Analysts now set their fair value estimate for SRF at ₹2,218, compared with the previous ₹2,244. This reflects updated assumptions around discount rate, revenue growth, profit margins and future P/E expectations.
Actualización de narrativa Feb 23

503806: Elevated P E And Modest Margin Outlook Will Likely Pressure Returns

Analysts have slightly raised their price target on SRF to ₹2,244, citing updated assumptions for the discount rate, revenue growth, profit margin and future P/E. These changes keep their fair value view broadly unchanged in headline terms but reflect a modestly adjusted risk and earnings profile.
Actualización de narrativa Feb 09

503806: Lower Margins And Rich P E Will Likely Pressure Returns

Analysts have raised their price target on SRF to ₹2,244 from ₹2,213, citing updated assumptions on the discount rate, revenue growth, profit margins and a higher future P/E multiple. What's in the News The board has approved the appointment of Mr. Samir Kashyap as Chief Financial Officer, effective January 27, 2026.
Actualización de narrativa Jan 24

503806: New Pharma Plant And CFO Appointment Will Support Future Upside

Analysts have trimmed their price target on SRF to ₹3,155.83 from ₹3,183.00, reflecting slightly more conservative assumptions on revenue growth, profit margin and future P/E, as well as a marginally higher discount rate. What's in the News Board meeting on January 20, 2026 to review unaudited financial results for the quarter and nine months ended December 31, 2025, consider a new pharma intermediate plant project, and discuss a second interim dividend for FY 2025-26 (company filing).
Actualización de narrativa Jan 10

503806: Future Capacity Expansion And CFO Transition Will Support Long Term Prospects

Analysts have kept their fair value estimate for SRF steady at ₹3,841, with only small tweaks to assumptions such as the discount rate, revenue growth, profit margin and future P/E that feed into the updated target. This signals broadly consistent expectations compared with prior research.
Actualización de narrativa Dec 26

503806: Future Specialty Fluoropolymer Capacity Expansion May Support Long Term Profitability

Analysts have modestly raised their price target on SRF to a new level, in line with incremental improvements in projected revenue growth, profit margins, and a slightly lower future valuation multiple, signaling a cautiously stronger outlook for the stock. What's in the News Chief Financial Officer Rahul Jain will step down from his role at the close of business on 12 December 2025, with SRF initiating the process to identify a successor and ensure a smooth transition (Key Developments).
Actualización de narrativa Dec 12

503806: Lower Discount Rate May Support Stronger Long Term Profitability

Analysts have raised their fair value estimate for SRF by approximately $191 to $3,841 per share, citing a modestly lower discount rate and slightly higher long term profit margin expectations that more than offset a small reduction in projected revenue growth. What's in the News Chief Financial Officer Rahul Jain will step down from his role at the close of business on 12 December 2025.
Actualización de narrativa Nov 27

503806: CFO Transition And New Facility Approval Will Drive Upside Ahead

Analysts have adjusted their price target for SRF slightly upward from $3,182.93 to $3,183.00, citing minor changes in underlying financial assumptions such as discount rate and projected margin. What's in the News Chief Financial Officer Rahul Jain will step down at the close of business on December 12, 2025.
Actualización de narrativa Nov 12

503806: Upcoming CFO Departure And Facility Decision Will Shape Outlook

Analysts have raised their price target for SRF from $3,138.07 to $3,182.93, citing updated forecasts that reflect slight adjustments in growth and profitability assumptions. What's in the News SRF Limited's Chief Financial Officer, Rahul Jain, announced he will step down from his position at the close of business on December 12, 2025.
Actualización de narrativa Oct 29

New Facility And Supply Chain Moves Will Drive Balanced Opportunity Ahead

Analysts have slightly raised their price target for SRF from $3,137.83 to $3,138.07, citing improved profit margin projections as well as a modest increase in anticipated revenue growth. What's in the News SRF Limited will hold a Board Meeting on October 27, 2025, to consider and approve the un-audited financial results for the quarter and half year ended September 30, 2025.
Actualización de narrativa Oct 15

Sustainability And Capacity Upgrades Will Transform Specialty Chemicals

Analysts have increased their price target for SRF from $3,104.79 to $3,137.83, reflecting updated expectations for the company's financial outlook. What's in the News The Chemours Company and SRF Limited have signed strategic agreements to enhance the global supply chain for fluoropolymers and fluoroelastomers (Key Developments).
Actualización de narrativa Sep 05

Sustainability And Capacity Upgrades Will Transform Specialty Chemicals

With no meaningful change in either the discount rate or forward P/E multiple, analysts have maintained SRF's fair value estimate at ₹3105. What's in the News SRF Limited has entered into strategic agreements with The Chemours Company to strengthen Chemours' global supply chain for fluoropolymers and fluoroelastomers, leveraging SRF's manufacturing capabilities.
User avatar
Nueva narrativa Nov 28

Specialty Chemicals Innovations And Global Demand Empower Revenue Growth Journey

SRF's Specialty Chemicals growth and increased production should drive revenue and improve margins due to new product launches and efficiency gains.

Previsiones de crecimiento de beneficios e ingresos

BSE:503806 - Estimaciones futuras de los analistas y datos financieros pasados (INR Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
3/31/2029230,01229,39517,04339,5748
3/31/2028203,05926,82712,48835,23029
3/31/2027178,19822,3397,28130,99128
3/31/2026157,86518,3527,38325,536N/A
12/31/2025154,84717,792N/AN/AN/A
9/30/2025152,63516,17614,28929,412N/A
6/30/2025150,47614,309N/AN/AN/A
3/31/2025146,93112,50812,56024,875N/A
12/31/2024139,49511,469N/AN/AN/A
9/30/2024135,11211,2932,65817,085N/A
6/30/2024132,64312,286N/AN/AN/A
3/31/2024131,38513,357-1,23120,939N/A
12/31/2023133,46914,760N/AN/AN/A
9/30/2023137,63517,334-2,97226,742N/A
6/30/2023143,13919,136N/AN/AN/A
3/31/2023148,70321,62363529,017N/A
12/31/2022146,41622,055N/AN/AN/A
9/30/2022145,17822,002-37423,714N/A
6/30/2022136,29021,016N/AN/AN/A
3/31/2022124,33718,8892,73721,057N/A
12/31/2021114,91916,647N/AN/AN/A
9/30/2021102,92414,8345,47820,051N/A
6/30/202195,54314,167N/AN/AN/A
3/31/202184,00011,9835,57317,717N/A
12/31/202076,50210,110N/AN/AN/A
9/30/202073,54310,3223,51915,172N/A
6/30/202069,9139,174-1,40911,708N/A
3/31/202072,0949,159-84713,044N/A
12/31/201978,8179,511N/AN/AN/A
9/30/201978,4117,592N/A13,433N/A
6/30/201971,2166,331N/AN/AN/A
3/31/201970,9965,916N/A8,956N/A
12/31/201872,3295,747N/AN/AN/A
9/30/201866,6605,402N/AN/AN/A
6/30/201860,3704,917N/AN/AN/A
3/31/201855,8904,617N/A6,780N/A
12/31/201753,0264,670N/AN/AN/A
9/30/201750,3854,442N/AN/AN/A
6/30/201748,9524,642N/AN/AN/A
3/31/201748,2185,150N/A6,454N/A
12/31/201645,8334,787N/AN/AN/A
9/30/201645,4594,709N/AN/AN/A
6/30/201645,9804,537N/AN/AN/A
3/31/201645,9274,299N/A10,900N/A
12/31/201545,3533,746N/AN/AN/A
9/30/201545,5113,453N/AN/AN/A
6/30/201545,7593,235N/AN/AN/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (16.5% al año) de 503806 es superior a la tasa de ahorro (6.9%).

Beneficios vs. Mercado: Se prevé que los beneficios (16.5% al año) de 503806 crezcan más rápidamente que el mercado Indian (16.4% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de 503806 crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (12.2% al año) de 503806 crezcan más rápidamente que los del mercado Indian (10.6% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 12.2% al año) de 503806 crezcan más despacio que 20% al año.


Previsiones de crecimiento de los beneficios por acción


Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de 503806 sea baja dentro de 3 años (15.8%).


Descubre empresas en crecimiento

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/05/20 01:05
Precio de las acciones al final del día2026/05/20 00:00
Beneficios2026/03/31
Ingresos anuales2026/03/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

SRF Limited está cubierta por 42 analistas. 31 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
null null360 ONE Capital Market Private Limited
Kumar Saumya SinghAmbit Capital
Nitin BhasinAmbit Capital